Diagnosis

  • Study reveals why women more likely to develop PTSD

    High brain oestrogen may raise women’s PTSD risk if severe stress strikes during high oestrogen phases, causing memory problems and stronger fear responses, new research has revealed. The study found that exposure to several simultaneous stressors can lead to persistent memory problems, difficulty recalling events and stronger reactions to trauma reminders. Tallie Baram [...]

  • Study reveals gap between perimenopause expectations and experience

    A study of 17,494 people has revealed a gap between perimenopause symptoms people expect and those they report, with fatigue and exhaustion far outranking hot flushes. While 71 per cent associated perimenopause with hot flushes, those reporting perimenopause cited exhaustion (95 per cent) and fatigue (93 per cent) far more often. Among more than 12,000 [...]

  • Blood pressure care after giving birth could protect brain health

    Women with high blood pressure in pregnancy may protect their brain health through better blood pressure management after giving birth, research has found. Women who monitored and managed their blood pressure at home, with remote doctor support, had larger white matter volumes nine months after birth than those receiving standard postnatal care. White matter links [...]

  • ‘Forever chemicals’ may increase gestational diabetes risk in pregnant women

    Pregnant women exposed to 'forever chemicals' could be at greater risk of developing gestational diabetes, a recent study suggests. PFAS (per- and polyfluoroalkyl substances) are toxic chemicals that do not break down in the body, leaching from non-stick cookware, waterproof textiles and takeaway containers into food or via skin contact and building up in vital [...]

  • Doctors point to cost of living as abortions reach record high

    The rising cost of living and poor contraception access have pushed the abortion rate in England and Wales to a record high since 1967, providers and doctors say. Government statistics released on Thursday showed terminations increased by 11 per cent in 2023 compared with the previous year. The age-standardised rate for women was 23.0 per [...]

  • Endomag Magtrace device gains EU MDR approval

    The Magtrace lymphatic tracer has become the latest Endomag device to receive EU Medical Device Regulation (EU MDR) certification, marking the final step in securing approval across the full Endomag surgical platform. This announcement follows the approval of the Magseed marker in October 2025, meaning that all technologies across the Sentimag portfolio have now been [...]

  • Research aims to shed light on chronic UTIs

    A new database on chronic urinary tract infections aims to help explain why millions of women and girls worldwide develop persistent infections that can defy treatment. A growing body of research suggests persistent, antibiotic-resistant UTIs may be caused by bacteria that embed deep within the bladder wall, potentially evading both the immune system and conventional [...]

  • Female-led antimicrobial resistance startup secures €24 million

    ShanX Medtech, a female-led AMR diagnostics startup, has secured €24m to scale its rapid antimicrobial susceptibility testing (AST) technology. The Eindhoven-based company has closed a €15m seed round and been awarded an €8.85m European Commission contract developed by the Health Emergency Preparedness and Response Authority in collaboration with the European Health and Digital Executive Agency. [...]

  • US approves at-home HPV testing

    The US has approved guidance allowing at-home HPV testing for women aged 30 to 65 at average risk for the first time. The Department of Health and Human Services announced updated cervical cancer screening guidance on Monday, permitting women aged 30 to 65 at average risk to collect a vaginal swab at home and mail [...]

  • Round up: FemHealth Ventures closes oversubscribed US$65m Fund II, and more

    Femtech World explores the latest business developments in the world of women’s health. FemHealth Ventures closes oversubscribed US$65m Fund II FemHealth Ventures, a women’s health-focused venture capital firm, has closed on FemHealth Ventures Fund II at US$65m. The oversubscribed raise brings the firm’s assets under management to US$100m across two funds and further solidifies FemHealth [...]